Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver of multisystem inflammatory syndrome in children (MIS-C) following COVID-19. Blocking TGFβ may offer a potential new treatment for this life-threatening condition.
Pip Care Raises $5M for AI-Powered Surgical Journey Platform
What You Should Know: – Pip Care, a company revolutionizing the surgical experience for patients and care teams, has successfully raised $5 million in Series